Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
1214
-
Total 13F shares, excl. options
-
74.3M
-
Shares change
-
+1M
-
Total reported value, excl. options
-
$39.9B
-
Value change
-
+$624M
-
Put/Call ratio
-
1.27
-
Number of buys
-
597
-
Number of sells
-
-505
-
Price
-
$536.34
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q2 2025
1,342 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q2 2025.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 1,214 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74.3M shares
of 80.8M outstanding shares and own 91.93% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.88M shares), BlackRock, Inc. (8.37M shares), STATE STREET CORP (3.55M shares), Fundsmith LLP (2.64M shares), GEODE CAPITAL MANAGEMENT, LLC (2.46M shares), BAMCO INC /NY/ (2.03M shares), MORGAN STANLEY (1.66M shares), Bank of New York Mellon Corp (1.45M shares), POLEN CAPITAL MANAGEMENT LLC (1.2M shares), and Invesco Ltd. (1.16M shares).
This table shows the top 1214 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.